Cormorant Asset Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,170,870
| Closed | -$4.03M | – | 53 |
|
|
2024
Q1 | $4.03M | Sell |
1,170,870
-10,245
| -0.9% | -$35.2K | 0.18% | 56 |
|
|
2023
Q4 | $2.91M | Hold |
1,181,115
| – | – | 0.14% | 46 |
|
|
2023
Q3 | $2.01M | Hold |
1,181,115
| – | – | 0.12% | 45 |
|
|
2023
Q2 | $3.54M | Hold |
1,181,115
| – | – | 0.2% | 50 |
|
|
2023
Q1 | $3.17M | Sell |
1,181,115
-2,499,250
| -68% | -$6.7M | 0.21% | 54 |
|
|
2022
Q4 | $30.4M | Buy |
3,680,365
+1,499,250
| +69% | +$12.4M | 2.03% | 14 |
|
|
2022
Q3 | $16.8M | Buy |
2,181,115
+142,900
| +7% | +$1.1M | 1.17% | 30 |
|
|
2022
Q2 | $5.81M | Hold |
2,038,215
| – | – | 0.44% | 48 |
|
|
2022
Q1 | $10.2M | Buy |
2,038,215
+357,100
| +21% | +$1.79M | 0.78% | 40 |
|
|
2021
Q4 | $33M | Sell |
1,681,115
-134,431
| -7% | -$2.64M | 1.96% | 14 |
|
|
2021
Q3 | $53.5M | Sell |
1,815,546
-136,172
| -7% | -$4.01M | 2.17% | 13 |
|
|
2021
Q2 | $82.7M | Sell |
1,951,718
-240,342
| -11% | -$10.2M | 2.81% | 8 |
|
|
2021
Q1 | $110M | Sell |
2,192,060
-100,000
| -4% | -$5.01M | 2.45% | 7 |
|
|
2020
Q4 | $75.4M | Buy |
+2,292,060
| New | +$75.4M | 1.79% | 13 |
|